Woofun AI reports that Canton Strategic Holdings, Inc. (CNTN) has completed the divestiture of its biotech R&D division, Gravitas Life Sciences, LLC, to Gravitas Collective Corp. The transaction, unanimously approved by the board, closed on July 17, 2026, signaling a strategic pivot away from life sciences.

The company indicated this move is a key step in its transformation into an operating entity focused on the digitalization of traditional financial markets through the Canton Network. Previously known as Tharimmune, Canton Strategic Holdings continues to support the ecosystem via Canton Coin and maintains its role as a strategic investor.